Related Experiment Videos
[Selenium and vitamin E in patients with progressive muscular dystrophy]
J Voirin1, G Deschrevel, J Y Guincestre
1Consultation des Pathologies Neuro-musculaires, CHRU de Caen.
Annales De Pediatrie
|June 1, 1990
Summary
Serum selenium and vitamin E levels in children with Duchenne muscular dystrophy did not differ from controls. However, these antioxidants may play a role in the disease
Area of Science:
- Biochemistry
- Pediatric Neurology
- Nutritional Science
Context:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting muscle function.
- Previous research has suggested altered antioxidant levels in DMD, but findings are inconsistent.
- This study examines serum selenium and vitamin E in pediatric patients with DMD.
Purpose:
- To prospectively investigate serum concentrations of selenium and vitamin E in children diagnosed with Duchenne muscular dystrophy.
- To compare these levels against a control group to identify potential differences.
- To explore the possible role of these antioxidants in the pathophysiology of DMD.
Summary:
- Serum levels of selenium and vitamin E were measured in children with Duchenne muscular dystrophy of varying ages and disease severity.
- Contrary to some prior studies, no significant differences in these antioxidant levels were observed when compared to healthy controls.
- The researchers hypothesize that selenium and vitamin E may still contribute to the underlying disease mechanisms of pseudohypertrophic muscular dystrophy.
Impact:
- This research provides novel data on antioxidant status in pediatric DMD patients, challenging previous assumptions.
- Findings suggest a potential, yet unconfirmed, role for selenium and vitamin E in DMD pathophysiology.
- An ongoing supplementation study aims to further elucidate the therapeutic potential of these antioxidants in DMD.